Background
==========

The bacterial genus *Xanthomonas* comprises a number of Gram-negative plant pathogenic bacteria that cause a variety of severe plant diseases \[[@B1]\]. *Xanthomonas citri* subsp. *citri*, the phytopathogen causing citrus canker, invades host plant tissues entering through stomata or wounds and then colonizes the apoplast of fruit, foliage and young stems, causing raised corky lesions and finally breaking the epidermis tissue due to cell hyperplasia, thus allowing bacterial dispersal to other plants \[[@B2]\].

Persistent and severe disease can lead to defoliation, dieback and fruit drop, reducing yields and causing serious economic losses \[[@B3]\]. To date, no commercial citrus cultivars are resistant to citrus canker and current control methods are insufficient to manage the disease \[[@B3]\]. Thus, there is a need to study the infection process in order to enable the development of new tools for disease control. Furthermore, the study of *X. citri*-citrus interactions has been used as a model to provide new advances in the understanding of plant-pathogen interactions \[[@B1]\].

The Type III protein secretion system (T3SS) is conserved in many Gram-negative plant and animal pathogenic bacteria \[[@B4]\]. The T3SS is subdivided into (i) the non-flagellar T3SS (T3aS) involved in the assembly of the injectisome or hypersensitive response and pathogenicity (Hrp) pilus, and (ii) the flagellar T3SS (T3bS), responsible for assembly of the flagellum \[[@B5]\]. The T3SS spans both bacterial membranes and is associated with an extracellular filamentous appendage, termed 'needle' in animal pathogens and 'Hrp pilus' in plant pathogens, which is predicted to function as a protein transport channel to the host-pathogen interface \[[@B4]\]. Translocation of effector proteins across the host membrane requires the presence of the T3SS translocon, a predicted protein channel that consists of bacterial Type III-secreted proteins \[[@B6]\].

A number of surface appendages, such as conjugative pili, flagella, curli, and adhesins have been shown to play a role in biofilm formation \[[@B7],[@B8]\]. The role of T3SS as an effector protein delivery machine is well established, however, whether this secretion system participates in multicellular processes such as biofilm formation remains unanswered. Several studies concluded that T3SS is only necessary for pathogenicity and that expression of this secretion system is repressed in biofilm-growing bacteria. For example, *Pseudomonas aeruginosa* PA14 *sadRS* mutant strains that cannot form biofilms have enhanced expression of T3SS genes, while a *P. aeruginosa* PA14 T3SS mutant exhibits enhanced biofilm formation compared to wild type strain \[[@B9]\]. Furthermore, in *Yersinia pseudotuberculosis*, it has been shown that the T3SS needle blocks biofilm formation in the model host *Caenorhabditis elegans*\[[@B10]\]. In contrast, other studies highlighted the role of T3SS in bacterial biofilm formation. Microarray experiments performed in *P. aeruginosa* cystic fibrosis epidemic strain AES-2 showed expression of T3SS encoding genes up-regulated in biofilms as compared to planktonic bacteria \[[@B11]\]. In the plant pathogen *Erwinia chrysanthemi*, it has been shown that the T3SS pilus is involved in the aggregative multicellular behavior that leads to pellicle formation \[[@B12]\]. The enterohemorrhagic *Escherichia coli* O157 has a well-defined T3SS, termed *E. coli* Type III secretion system 1 (ETT1), which is involved in attachment and effacement and is critical for virulence. This strain also has a gene cluster potentially encoding an additional T3SS (ETT2) \[[@B13]\]. Studies on an ETT2 deletion mutant strain showed that although ETT2 is not responsible for protein secretion, it is involved in biofilm formation and hence in virulence \[[@B13]\]. Recently, it has been shown that the *Salmonella enterica* serovar *Typhimurium* T3SS secretion system SPI-1 is involved in the formation of an adherent biofilm and cell clumps in the culture media \[[@B14]\]. Taken together, the evidence suggests that T3SS may play a role in bacterial biofilm formation.

In *X. citri*, biofilm formation is required for optimal virulence as revealed by several reports with different bacterial mutants. For instance, *X. citri* mutants that are unable to biosynthesize molecules needed for biofilm formation such as exopolysaccharide (EPS), an adhesin protein and the lipopolysaccharide show a reduced virulence \[[@B15]-[@B17]\]. Consistent with this, *X. citri* infection is reduced by foliar application of compounds that are able to inhibit *X. citri* biofilm formation \[[@B18]\]. The role of *X. citri* T3SS in pathogenicity is well known since T3SS mutants are unable to grow in host plants indicating that *X. citri* T3SS is responsible for the secretion of effector proteins \[[@B19]\]. Taking into account that biofilm formation is a requirement for *X. citri* to achieve full virulence, we have characterized the ability of a T3SS mutant to form biofilms and by performing a proteomic analysis we have identified differentially expressed proteins with a view to obtain a greater understanding of this process.

Results
=======

The T3SS contributes to *X. citri in vitro* biofilm formation
-------------------------------------------------------------

In order to study the role of the T3SS in *X. citri* biofilm formation, a *X. citri* T3SS mutant in the *hrpB* operon termed *hrpB*^−^ mutant \[[@B19]\] was characterized in their ability to form a biofilm compared to the wild type strain. The *hrpB*^*−*^ mutant was previously obtained by single crossover plasmid integration in the region that comprises the 3′ end of hrpB5 and the 5′ region of the ATPase *hrcN*\[[@B19]\] (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1A). Here, in order to complement this strain, *hrpB5* and *hrcN* were cloned in frame in the expression plasmid pBBR1MCS-5 under the control of the *lacZ* promoter \[[@B20]\]. However, the resulting strain did not restore biofilm formation or pathogenicity (data not shown) suggesting that downstream genes of the *hrpB* operon, *hrpB7* and *hrcT*, may be also affected in the *hrpB*^*−*^ mutant due to polarity effects (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1A). Therefore, the entire region containing *hrpB5*, *hrcN*, *hrpB7* and *hrcT* was cloned in the pBBR1MCS-5 vector (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1A) and the resulting strain (*hrpB*^*−*^c) was tested for its ability to trigger HR in non-host plants and disease in citrus leaves (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1B and S1C). As expected, the HR response in non-host plants was similar for the *hrpB*^*−*^c strain and *X. citri* (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1B). In host tissue infections, the *hrpB*^*−*^c strain did cause lesions, though it was less virulent than *X. citri*, showing a reduction in water soaking and in canker lesion formation (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1C). A partial complementation was also observed by RT-qPCR assays of *CsLOB1*. This gene encodes a protein that is a member of the Lateral Organ Boundaries (LOB) gene family of transcription factors whose expression is induced by the *X. citri* TAL effector protein PthA4 \[[@B21],[@B22]\]. As expected, in leaves infected with *X. citri,* an induction of *CsLOB1* was observed, the *hrpB*^*−*^ mutant did not induce the expression of this gene suggesting that this mutant is not secreting PthA4 and the *hrpB*^*−*^c strain induced *CsLOB1* expression albeit at lower levels than *X. citri* probably due a lower amount of PthA4 secreted by this strain (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1D). Given of the possibility that bacteria may be loosing the plasmids during the host plant assays, bacteria were extracted from plant tissues and quantified at different times using appropriate antibiotics and no loss of plasmid was observed even 30 days after infiltrations (data not shown). Therefore, this partial complementation may be due to the fact that these genes are expressed under the *lacZ* promoter and that expression levels are likely to be somewhat different from those of the endogenous genes. This proposition is supported by recent work that shows that *lac* promoter-driven expression of *hrpB1* only partially complemented the *hrpB1* mutant phenotype in susceptible plants, while complete complementation was observed for HR in pathogen resistant plants \[[@B23]\]. For the biofilms assays, first the strains were cultured statically in 24-well PVC plates in XVM2. After seven days of growth, *X. citri* and *hrpB*^−^c strain were able to form mature biofilms with a conformation similar of that previously observed for *X. citri* strain \[[@B16]\], while the *hrpB*^−^ mutant showed impaired biofilm formation (Figure [1](#F1){ref-type="fig"}A). Next, the strains were grown statically in borosilicate glass tubes in XVM2 medium for seven days. Staining of bacterial cells with the specific crystal violet (CV) stain showed that under these conditions *X. citri* and *hrpB*^−^c strain can form biofilms of cells that adhere to the glass surface forming a thick ring at the air--liquid surface--interface of the culture medium, whereas the *hrpB*^−^ mutant was altered in its ability to form such a structure. Instead, the *hrpB*^−^ mutant formed only a narrow ring of cells (Figure [1](#F1){ref-type="fig"}B). CV staining of *X. citri* and *hrpB*^−^c strains was over nine times greater than that of the *hrpB*^−^ mutant (p \< 0.05) (Figure [1](#F1){ref-type="fig"}C), thereby confirming a reduction in the capacity of biofilm formation for the mutant. Since the *hrpB*^*−*^ mutant is a polar mutant, in order to discern whether the *hrpB5-hrcT* genes or the 'Hrp pilus' are involved in the process of biofilm formation, the *hrpD*^*−*^ and *hrpF*^*−*^ mutants previously obtained were analyzed \[[@B19]\] (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1A). These two mutants, like the *hrpB*^*−*^ mutant, were impaired in biofilms formation (Figure [1](#F1){ref-type="fig"}A, [1](#F1){ref-type="fig"}B and [1](#F1){ref-type="fig"}C). All strains showed similar growth rates in XVM2 medium under agitation, with a generation time of 200 min, indicating that mutations of *hrp* genes do not impair growth of the *hrp* mutants *in vitro* (data not shown). Further, differences in statically growing cells were analyzed by confocal laser scanning microscopy using *X. citri* and *hrpB*^*−*^ strains transformed with a pBBR1MCS-5 vector that carries a copy of the *gfp* gene (pBBR1MCS-5EGFP). The analysis showed that *X. citri* formed large clusters of aggregated cells that were not observed in the *hrpB*^−^ mutant (Figure [2](#F2){ref-type="fig"}). Moreover, serial images taken at 0.5 μm-distance (vertical z-stack) covering the entire well length revealed that *X. citri* formed thick bacterial biofilms of about 250 μm deep, while the *hrpB*^−^ mutant formed narrower unstructured biofilms of 50 μm in length (Figure [2](#F2){ref-type="fig"}).

![**Biofilm assays for*X. citri*, the*hrp*mutants and the*hrpB***^**−**^**c strain.** Representative photographs of biofilm formation assays for *X. citri*, *hrp* mutants and *hrpB*^−^c strains grown statically in 24-well PVC plates **(A)** or in borosilicate glass tubes **(B)** for seven days in XVM2 medium. **(C)** Quantification of biofilm formation by CV stain measured spectrophotometrically (Abs. at 600 nm). Relative Abs. indicates: CV Abs. 600 nm/Planktonic cells Abs. 600 nm. Values represent the mean from seven tubes for each strain. Error bars indicate the standard deviation.](1471-2180-14-96-1){#F1}

![**Confocal laser scanning microscopy analysis of*X. citri*and*hrpB***^**−**^**strains grown statically.** GFP-expressing *X. citri* and *hrpB*^−^ strains cultured statically *in vitro* were analyzed by confocal laser scanning microscopy, serial images were taken at 0.5 μm distances (vertical z-stack). Z represents the ZX axis projected images. At the XY images, white arrows point to *X. citri* clusters of aggregated cells.](1471-2180-14-96-2){#F2}

The T3SS is not required for attachment to host tissue but is necessary for *X. citri* biofilm formation on the leaf surface
----------------------------------------------------------------------------------------------------------------------------

The role of *X. citri* T3SS in bacterial adherence, like attachment to plant tissue, was evaluated by quantitative measurement of CV staining of adhered cells to leaf tissues. *X. citri* wild type and all the *hrp* mutants adhered proficiently and to the same extent to leaf tissues (p \< 0.05) (Figure [3](#F3){ref-type="fig"}A), indicating that T3SS is not involved in leaf surface attachment. In order to analyze biofilm growth of GFP-expressing *X. citri* and *hrpB*^−^ strains on host leaf surfaces, bacterial drops were spread over the abaxial surface of citrus leaves and growth was examined confocal laser scanning microscopy. Under these conditions, *X. citri* cells grew and formed biofilm structures over the entire area of the drops on the leaf surface, with a higher density of cells accumulated at the border forming a circle (Figure [3](#F3){ref-type="fig"}B). The *hrpB*^−^ mutant growth was limited compared to *X. citri*, forming only small cell cumuli at the center and a narrower border circle. Further examination of the 0.5 μm stacks at the circle borders showed that *X. citri* formed a thicker bacterial biofilm of about 20 μm, while the *hrpB*^−^ mutant formed a narrower border of about 7.5 μm. These results indicate that the absence of the T3SS negatively affects biofilm formation.

![**Adherence of the*hrp*mutants to citrus leaf tissues and confocal laser scanning microscopy analysis on citrus leaves of*X. citri*and*hrpB***^**−**^**strains. (A)** Quantitative measurement of the CV retained by *X. citri* and *hrp* mutant strains adhered to abaxial leaf surfaces. Values represent the means of 20 quantified stained drops for each strain. Error bars indicate standard deviations. **(B)** Representative photographs of confocal laser scanning microscopy analysis of GFP-expressing *X. citri* and *hrpB*^−^ cells grown on leaf surfaces. Below each of the fluorescent photographs of both strains, the ZX axis projected images accumulated over serial imaging taken at 0.5 μm distances (z-stack) are shown. Scale bars: 0.5 mm.](1471-2180-14-96-3){#F3}

T3SS is required for *X. citri* leaf-associated survival
--------------------------------------------------------

The expression profiles of genes involved in T3SS formation such as *hrpG* and *hrpX*, encoding for the two regulators of the *hrp* cluster \[[@B24]\], and *hrpE*, the major structural component of the 'Hrp pilus' \[[@B25]\] were evaluated in *X. citri* cells recovered from leaf surfaces at different times by RT-qPCR assays. A significant induction of the expression of these genes (p \< 0.05) was detected after two days post-spraying of the bacteria on leaf surfaces (Figure [4](#F4){ref-type="fig"}A). Next, populations of the different strains were quantified at different times post-spraying on citrus leaf surfaces. One week after initial inoculation, the population size of *X. citri* decreased by almost one order of magnitude. Under these conditions, *X. citri* cannot enter through the tissue and replicate due to the thickness of the citrus leaf cuticle \[[@B16]\]. As a consequence, bacterial cell numbers remained relatively steady throughout the subsequent three weeks of growth. The population size of *X. citri* was nearly one order of magnitude higher at every time point analyzed (p \< 0.05) as compared to the *hrp* mutants (Figure [4](#F4){ref-type="fig"}B). The population of the *hrpB*^−^c did not achieve *X. citri* levels, but was ever higher than that of the *hrp* mutants (Figure [4](#F4){ref-type="fig"}B). These results support the idea that the T3SS is necessary for *X. citri* colonization of the phyllosphere, which may be due, at least partly, to the role of T3SS in *X. citri* biofilm formation.

![**Analysis of T3SS gene expression in leaf-associated grown*X. citri*and survival of*X. citri*,*hrp*mutants and*hrpB***^**−**^**c cells associated to leaves. (A)** RT-qPCR to determine *hrpG*, *hrpX* and *hrpE* expression levels in *X. citri* grown associated to leaves. Bars indicate the expression levels of the T3SS genes at two days of leaf-associated growth relative to time 0. Values are the means of four biological replicates with three technical replicates each. **(B)***X. citri*, *hrp* mutants and *hrpB*^−^c strains leaf-associated survival on citrus leaves. Values represent an average of four leaves assayed for each strain. Error bars indicate the standard deviation.](1471-2180-14-96-4){#F4}

Proteomic analysis of statically cultured *X. citri* and *hrpB*^−^ strains
--------------------------------------------------------------------------

In order to gain new insights about the role of T3SS in biofilm formation, a proteomic analysis was performed to identify differentially expressed proteins between *X. citri* and the *hrpB*^*−*^ mutant grown statically. A total of 49 differentially expressed protein spots were detected of which 32 were up- and 17 down-regulated in the *hrpB*- mutant in comparison to *X. citri* (Table [1](#T1){ref-type="table"}). Identified proteins were used to determine enriched GO categories in biological processes and molecular function. The main enriched categories for the up- and down-regulated proteins with an average fold change of minimum ± 1.5 and p value \< 0.05 in the *hrpB*^−^ mutant relative to *X. citri* were represented graphically (Figure [5](#F5){ref-type="fig"}). The categories that showed a major enrichment in the up-regulated proteins in the *hrpB*- mutant include 'metabolic process', 'catabolic process', 'biosynthetic process' and 'generation of precursor metabolites and energy'. Moreover, 'cell cycle', 'cellular homeostasis' and 'cellular process' were categories enriched in up-regulated proteins in this mutant. Most of the identified proteins in the categories of 'transporter activity' or 'receptor activity' belong to different classes of outer membrane proteins (OMPs) such as: FadL (XAC0019), that allows the passage of fatty acids \[[@B26]\], OmpW (XAC3664), involved in the transport of small hydrophilic molecules across the bacterial outer membrane \[[@B27]\] and RpfN (XAC2504), which was reported to play a role in carbohydrate transport \[[@B28]\]. In these categories also several TonB-dependent transporters (TBDTs), which are outer membrane transporters involved in the active uptake and/or in signal transduction \[[@B29]\], as well as two Oar (OmpA-related) proteins were detected as differentially expressed between the two strains.

###### 

**Differentially expressed protein spots between*X. citri*and*hrpB***^**−**^**strains statically cultured in XVM2 with a change abundance of minimum 1.5 fold and p value of \< 0.05 (ANOVA)**

  ***X. citri*gene no.**                                                 **Protein name**                                       **MOWSE score**   **Accession no.**   **Predicted MW/p*I***   **Observed MW/p*I***   **Peptide match/coverage**   **Fold change compared to WT**
  ---------------------------------------------------------------------- ----------------------------------------------------- ----------------- ------------------- ----------------------- ---------------------- ---------------------------- --------------------------------
  01 Metabolism                                                                                                                                                                                                                                  
  01.01 Amino acid metabolism                                                                                                                                                                                                                    
  XAC0125                                                                Aspartate/tyrosine/aromatic aminotransferase                 350           Q8PR41_XANAC            43.3/5.72               49.0/4.8                   19/38%                          1.9
  XAC4034                                                                Shikimate 5-dehydrogenase                                    297            AROE_XANAC             29.9/4.93               30.0/5.9                   19/17%                          2.4
  XAC2717                                                                Tryptophan synthase subunit b                                31             TRPB_XANAC             43.3/5.88               53.0/4.6                    2/4%                           7.5
  XAC3709                                                                Tryptophan repressor binding protein                         48            Q8PGA8_XANAC            20.0/6.40               10.0/4.4                   3/17%                           −1.6
  01.02 Nitrogen, sulfur and selenium metabolism                                                                                                                                                                                                 
  XAC0554                                                                NAD(PH) nitroreductase                                       208            Y554_XANAC             21.0/5.83               18.0/4.7                   14/38%                          4.6
  01.03 Nucleotide/nucleoside/nucleobase metabolism                                                                                                                                                                                              
  XAC1716                                                                CTP-synthase                                                 125            PYRG_XANAC             61.7/5.91               67.0/4.5                   14/21%                          3.5
  01.05 C-compounds and carbohydrate metabolism                                                                                                                                                                                                  
  XAC2077                                                                Succinate dehydrogenase flavoprotein subunit                 192           Q8PKT5_XANAC            65.8/5.89               66.0/4.6                   20/25%                          2.2
  XAC1006                                                                Malate dehydrogenase                                        1054             MDH_XANAC             34.9/5.37               45.0/5.4                   55/50%                          −1.8
  XAC3579                                                                Phosphohexose mutases (XanA)                                 98            Q8PGN7_XANAC            49.1/5.29               54.0/5.6                   7/10%                           1.7
  XAC3585                                                                DTP-glucose 4,6-dehydratase                                  235           Q8PGN1_XANAC            38.6/5.86               48.0/4.7                   12/17%                          2.1
  XAC0612                                                                Cellulase                                                    245           Q8PPS3_XANAC            51.6/5.76               57.0/4.9                   23/32%                          2.6
  XAC3225                                                                Transglycosylase                                             178           Q8PHM6_XANAC            46.2/5.89               53.0/4.8                   14/22%                          −1.6
  01.06 Lipid, fatty acid and isoprenoid metabolism                                                                                                                                                                                              
  XAC3300                                                                Putative esterase precursor (EstA)                           96            Q8PHF7_XANAC            35.9/6.03               62.0/6.2                    3/4%                           −3.1
  XAC1484                                                                Short chain dehydrogenase precursor                          104           Q8PME5_XANAC            26.0/5.97               30.0/4.4                    5/9%                           2.2
  01.06.02 Membrane lipid metabolism                                                                                                                                                                                                             
  XAC0019                                                                Outer membrane protein (FadL)                                167           Q8PRE4_XANAC            47.3/5.18               46.0/6.1                   8/10%                          −10.0
  XAC0019                                                                Outer membrane protein (FadL)                                79            Q8PRE4_XANAC            47.3/5.18               35.0/6.0                   7/13%                           −6.2
  01.20 Secondary metabolism                                                                                                                                                                                                                     
  XAC4109                                                                Coproporphyrinogen III oxidase                               46             HEM6_XANAC             34.6/5.81               37.0/4.9                   8/19%                           1.5
  02 Energy                                                                                                                                                                                                                                      
  02.01 Glycolysis and gluconeogenesis                                                                                                                                                                                                           
  XAC1719                                                                Enolase                                                      90              ENO_XANAC             46.0/4.93               55.0/5.9                   7/13%                           1.7
  XAC3352                                                                Glyceraldehyde-3-phosphate dehydrogenase                     267           Q8PHA7_XANAC            36.2/6.03               46.0/4.4                   24/28%                          2.6
  XAC2292                                                                UTP-glucose-1-phosphate uridylyltransferase (GalU)           92            Q8PK83_XANAC            32.3/5.45               38.0/5.3                   13/30%                          4.2
  02.07 Pentose phosphate pathway                                                                                                                                                                                                                
  XAC3372                                                                Transketolase 1                                              85            Q8PH87_XANAC            72.7/5.64               69.0/4.9                    5/7%                           5.0
  02.11 Electron transport and membrane-associated energy conservation                                                                                                                                                                           
  XAC3587                                                                Electron transfer flavoprotein a subunit                     50            Q8PGM9_XANAC            31.8/4.90               34.0/5.5                   6/14%                           2.3
  10 Cell cycle and DNA processing                                                                                                                                                                                                               
  10.03 Cell cycle                                                                                                                                                                                                                               
  XAC1224                                                                Cell division topological specificity factor (MinE)          33             MINE_XANAC             9.6/5.37                12.0/4.9                   1/14%                           2.7
  10.03.03 Cytokinesis/septum formation and hydrolysis                                                                                                                                                                                           
  XAC1225                                                                Septum site-determining protein (MinD)                       143           Q8PN48_XANAC            28.9/5.32               34.0/5.6                   19/26%                          2.3
  11 Transcription                                                                                                                                                                                                                               
  XAC0996                                                                DNA-directed RNA polymerase subunit a                        104            RPOA_XANAC             36.3/5.58               33.0/5.0                    5/7%                           −4.3
  XAC0966                                                                DNA-directed RNA polymerase subunit b                        150            RPOC_XANAC            155.7/7.82               35.0/4.6                   16/8%                           −3.3
  14 Protein fate (folding, modification and destination)                                                                                                                                                                                        
  14.01 Protein folding and stabilization                                                                                                                                                                                                        
  XAC0542                                                                60 kDa chaperonin (GroEL)                                    199            CH60_XANAC             57.1/5.05               41.0/5.5                   15/27%                         −11.2
  16 Protein with binding function or cofactor requirement                                                                                                                                                                                       
  XAC2726                                                                Adenine-specific methylase (Dam methylase)                   84            Q8PJ19_XANAC            33.9/4.70               41.0/6.2                   10/12%                          −1.9
  XAC1362                                                                GTN reductase                                                44            Q8PMR4_XANAC            39.4/5.37               50.0/5.3                   7/10%                           2.3
  XAC3664                                                                OmpW family outer membrane protein precursor                 226           Q8PN48_XANAC            23.8/4.97               28.0/6.2                   12/13%                          2.3
  30 Cellular communication/Signal transduction mechanism                                                                                                                                                                                        
  XAC0291                                                                Oar protein ( TonB-dependent transporter)                    50            Q8PQN2_XANAC           107.9/5.29              108.0/5.7                    2/1%                           4.3
  XAC2672                                                                Oar protein ( TonB-dependent transporter)                    280           Q8PJ70_XANAC           117.4/5.10               90.0/5.9                   19/18%                          2.4
  XAC4273                                                                TonB-dependent transporter                                   100           Q8PJL0_XANAC           109.2/5.14               90.0/5.6                    3/3%                           2.8
  XAC1143                                                                TonB-dependent transporter                                   576           Q8PND0_XANAC            87.7/5.21               70.0/6.1                   30/33%                          1.7
  XAC3050                                                                TonB-dependent transporter                                   596           Q8PI48_XANAC           105.8/4.76               64.0/6.2                   30/16%                          −3.0
  XAC3444                                                                TonB-dependent transporter                                  1280           Q8PH16_XANAC           103.2/4.79               90.0/6.3                   84/37%                          3.9
  XAC3168^\*^                                                            TonB-dependent transporter                                   98            Q8PHT1_XANAC            87.3/5.20               59.0/6.0                    3/3%                           −3.1
  XAC3166^\*^                                                            TonB-dependent transporter                                   410           Q8PHT3_XANAC            84.5/4.95               69.0/6.1                   22/18%                          −2.9
  XAC3489                                                                TonB-dependent transporter                                   685           Q8PGX3_XANAC            88.9/4.93               69.0/5.9                   40/24%                          −1.7
  XAC1413                                                                Outer membrane protein assembly factor BamA                  135           Q8PML3_XANAC            87.6/5.53               88.0/5.4                   13/15%                          2.8
  32 Cell rescue, defense and virulence                                                                                                                                                                                                          
  XAC2504^\*^                                                            Regulator of pathogenicity factors (RpfN)                    271           Q8PJM6_XANAC            41.3/5.98               49.0/4.4                   21/16%                          −4.8
  XAC0907                                                                Alkyl hydroperoxide reductase subunit C                      240           O06464_XANAC            20.6/6.15               20.0/4.2                   28/61%                          1.3
  32.07 Cellular detoxification                                                                                                                                                                                                                  
  XAC1474                                                                Glutathione transferase                                      39            Q8PMF5_XANAC            23.9/6.06               22.0/4.7                    4/8%                           1.7
  34 Interaction with the environment                                                                                                                                                                                                            
  34.01 Homeostasis                                                                                                                                                                                                                              
  XAC1149                                                                Bacterioferritin                                             100           Q8PNC4_XANAC            21.2/4.71               20.0/6.3                   6/20%                           2.1
  XAC0493                                                                Bacterioferritin                                             152           Q8PQ38_XANAC            18.3/4.80               12.0/6.5                   19/43%                          2.5
  XAC1533                                                                Dihydrolipoamide dehydrogenase                               336           Q8PM99_XANAC            50.5/5.80               59.0/4.6                   34/47%                          4.0
  42 Biogenesis of cellular components                                                                                                                                                                                                           
  XAC1230                                                                Putative membrane protein                                    71            Q8PN43_XANAC            43.1/6.88               24.0/4.4                   4/11%                           −3.5
  99 Unclassified proteins                                                                                                                                                                                                                       
  XAC1262                                                                Protein of unknown function (Aminopeptidase)                 121           Q8PN12_XANAC            63.4/5.85               68.0/4.6                   13/15%                          5.3
  XAC1344                                                                Protein of unknown function (CcmA)                           67            Q8PMT2_XANAC            18.7/5.45               23.0/5.7                   4/18%                           −1.7

\*Protein spots 240 and 398 were previously named "ferric enterobactin receptor" are now classified as TonB-dependent transporter, while protein spot 31 previously identified as "carbohydrate selective porin" and is now classified as Regulator of pathogenicity factors.

![**Gene ontology (GO) terms enriched in differentially expressed proteins between*X. citri*and*hrpB***^**−**^**static cells.** Proteins up-regulated and down-regulated in the *hrpB*^−^ mutant relative to *X. citri* in the main enriched categories are shown. The GO enrichment analysis was performed using Blast2GO.](1471-2180-14-96-5){#F5}

The lack a T3SS enhances *X. citri* EPS production and decreases bacterial motility
-----------------------------------------------------------------------------------

The proteomic assay detected an over-expression of the enzymes XanA and GalU in the *hrpB*^−^ mutant compared to *X. citri* (Table [1](#T1){ref-type="table"}). The XanA enzyme encodes a bifunctional phosphoglucomutase/phosphomannomutase involved in the synthesis of both glucose 1-phosphate and mannose 1-phosphate. Glucose 1-phosphate is then converted to UDP-glucose by GalU and mannose 1-phosphate to GDP-mannose by mannose 1-phosphate guanylyltransferase. These nucleotide sugars are directly implicated in EPS synthesis \[[@B30],[@B31]\]. Production of EPS was measured in *X. citri*, the *hrp* mutants and the *hrpB*^−^c strains and results showed that EPS production in these mutants was over 1.7 times that in *X. citri* and *hrpB*^−^c strain (p \< 0.05) (Figure [6](#F6){ref-type="fig"}A). Additionally, the expression of *gumD*, a gene encoding a protein of the EPS biosynthetic pathway, was analyzed by RT-qPCR in all the strains. The results showed that the transcript levels of *gumD* were over 17 times higher in *hrp* mutant strains as compared to *X. citri* and the *hrpB*^−^c strain (p \< 0.05) (Figure [6](#F6){ref-type="fig"}B). Moreover, the proteomic analysis also showed a down-regulation of the outer membrane protein XAC0019 in the *hrpB*^−^ mutant (Table [1](#T1){ref-type="table"}) and recently, it has been shown that this protein is necessary for *X. citri* swimming \[[@B32]\]. Furthermore, CcmA that is required for bacterial motility \[[@B33],[@B34]\] was also down-regulated in the *hrpB*^−^ mutant (Table [1](#T1){ref-type="table"}). Therefore, bacterial motility was assayed for the *hrp* mutants and results showed that *X. citri* and the *hrpB*^−^c strain moved about 2.5 and 1.25 further in swimming and swarming plates respectively, than the *hrp* mutants (p \< 0.05) (Figure [6](#F6){ref-type="fig"}C) (Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2).

![**EPS production and bacterial motility assays in*X. citri*, the*hrp*mutants and the*hrpB***^**−**^**c strains. (A)** Quantification of EPS present in the supernatant fraction of cultures of the different strains. Quadruplicate measurements were made for each strain and an average of all measurements was obtained. Error bars indicate standard deviations. **(B)** RT-qPCR assay to determine *gumD* expression of the different stains relative to *X. citri*. Values are the means of four biological replicates with three technical replicates each. **(C)** Quantification of bacterial swimming and swarming motility. Results are the average of the motility zones of 16 Petri dishes per strain. Error bars indicate the standard deviation.](1471-2180-14-96-6){#F6}

Discussion
==========

The role of T3SS in bacterial pathogenesis as a machine involved in effector protein delivery is well established, however, little is known about other functions in bacterial behavior that this system may have. Given that biofilm formation is required for *X. citri* to achieve full virulence, we used *X. citri* as a model to gain further insights into the functional role of T3SS in biofilm formation. By comparing the capacity of biofilm formation of three T3SS mutants and *X. citri* and also performing a proteomic assay with the *hrpB*^*−*^ mutant, which revealed differentially expressed proteins between both strains, we demonstrated that T3SS is involved in biofilm formation in *X. citri*.

To date the involvement of *X. citri* T3SS in bacterial attachment and survival on leaf tissue has not been studied. In this work we observed that the adherence of different T3SS mutants to host cell tissue was not altered. Studies in several pathogenic bacteria, such as *Salmonella typhimurium*\[[@B35]\], *E. coli*\[[@B36],[@B37]\] and the plant pathogen *P. syringae*\[[@B38]\] revealed that mutants unable to produce T3SS appendages become affected in their interactions with host cells. However, in the phytopathogen *Ralstonia solanacearum*, it has been shown that the lack of a T3SS pilus does not affect attachment to plant cells \[[@B39]\], and this is consistent with our observation that adherence of *X. citri* to the host tissue was not affected by the absence of a functional T3SS. In addition, we determined that T3SS is required for *X. citri* survival on citrus leaves and that T3SS genes are expressed while bacteria reside on the plant surface. Expression of T3SS genes on the leaf surface was also detected in *Xanthomonas euvesicatoria* cells suggesting a role for T3SS in epiphytic survival of the bacteria \[[@B40]\]. In a recent report, it was revealed that the survival of *Pseudomonas syringae* T3SS-deficient strains on leaf surfaces is reduced, supporting a role of T3SS and effector proteins in the promotion of epiphytic bacterial survival \[[@B41]\]. Our results suggest that T3SS plays a role in *X. citri* leaf-associated survival on the leaf surface by enabling biofilm formation.

The proteomic study revealed differentially expressed proteins between *X. citri* and the *hrpB*^*−*^ mutant strain and GO analysis detected enrichment of up-regulated proteins in different metabolic processes and generation of energy in the *hrpB*^−^ mutant. Similarly, in a previous proteomic study, these categories were also enriched with up-regulated proteins in *X. citri* planktonic cells compared to biofilm, suggesting a slower metabolism and reduction in aerobic respiration in the *X. citri* biofilm \[[@B42]\]. Therefore, the higher expression of proteins involved in these processes in the *hrpB*^−^ mutant compared to *X. citri* may be caused by the lack of biofilm formation of the mutant.

It is remarkable that among the differentially expressed proteins between the mutant and the wild type strain, some have been previously characterized as involved in biofilm formation in *X. citri* or in other pathogenic bacteria. Such is the case of DNA-directed RNA polymerase subunit β \[[@B32]\], tryptophan synthase \[[@B43]\], GroEL \[[@B44],[@B45]\], FadL \[[@B32],[@B42],[@B46]\] and several TBDTs \[[@B42],[@B47]\]. Interestingly, high intracellular L-tryptophan concentration prevents biofilm formation and triggers degradation of mature biofilm in *E. coli*\[[@B43]\]. The proteomic assay showed that tryptophan synthase (XAC2717) was up-regulated, while the tryptophan repressor binding protein (XAC3709) was down-regulated in *hrpB*^−^ strain suggesting a link also between tryptophan metabolism and biofilm formation in *X. citri*. Another example is the outer membrane protein XAC0019 that displays high homology to the fatty acid transport porin FadL. *Pseudomonas fluorescens* mutants in the *fadL* gene showed defects in their ability to develop a biofilm on a abiotic surfaces leading to the suggestion that long chain fatty acids bind to FadL thereby altering surface hydrophobicity, and adhesion characteristics \[[@B46]\]. Consistent with this, a recent work showed that a *X. citri* mutant in XAC0019 displays reduced capacity to form a biofilm \[[@B32]\] and its expression is increased during *X. citri* biofilm formation \[[@B42]\]. In the present study, XAC0019 protein was down-regulated in the *hrpB*^−^ mutant impaired in biofilm formation, reinforcing the role of this protein in this process.

Enzymes involved in EPS production XanA and GalU, \[[@B30],[@B31]\] were up-regulated in the *hrpB*^−^ mutant. Consistently, all the *hrp* mutant analyzed in this work produced larger amounts of EPS in comparison with *X. citri* and also had higher expression levels of *gumD*. Recent reports have shown that *X. citri galU* mutant strain is not pathogenic and also loses its capacity to form a biofilm due to a reduction in EPS production \[[@B30],[@B32]\], and that a *X. citri xanA* mutant has an altered capacity for biofilm formation \[[@B47]\]. Although, the *hrp* mutants are impaired in biofilm formation, these mutants produce more EPS than *X. citri*. This interesting result open new hypotheses about the link between T3SS and EPS production, thus further studies are needed to unravel this issue. In other pathogens, such as *P. aeruginosa*, T3SS gene expression is coordinated with many other cellular activities including motility, mucoidy, polysaccharide production, and also biofilm formation \[[@B48]\].

Bacterial motility was impaired in the *hrp* mutants and consistently, proteins known as involved in these processes such as the outer membrane protein XAC0019 \[[@B32]\] and the bactofilin CcmA \[[@B33],[@B34]\] were down-regulated in the *hrpB*^−^ mutant. Besides, swarming motility was less affected than swimming in the *hrp* mutants compared with *X. citri*. This may be due to the fact that in *X. citri* swarming motility depends on flagella and also on the amount of EPS secreted \[[@B16]\], and since these mutants over-produced EPS swarming was less affected than swimming.

This work demonstrated that in *X. citri* T3SS is involved in multicellular processes such as motility and biofilm formation. Furthermore, our results suggest that T3SS may also have an important role in modulating adaptive changes in the cell, and this is supported by the altered protein expression when this secretion system is not present. It was previously shown that an *E. coli* O157 strain mutant in the additional T3SS named ETT2 is impaired in biofilm formation \[[@B13]\]. It was also suggested that deletion of ETT2 might cause structural alterations of the membrane modifying bacterial surface properties, thus affecting bacteria-bacteria interactions or the interaction with host cells \[[@B13]\]. Further, it was proposed that these structural alterations could trigger a signal that activates differential gene expression and/or protein secretion \[[@B13]\]. In line with this, we propose that in *X. citri* the 'Hrp pilus' structure *per se*, or its interaction with a solid surface, stabilizes the outer membrane structure, hence the lack of T3SS may trigger membrane remodeling itself. These membrane modifications in turn may change the pattern of protein expression, leading to the impairment of cellular processes directly related to bacterial virulence including biofilm formation. Another possibility is that the 'Hrp pilus' may function like an attachment device or flagellum. Future studies are likely to add further insights into the exact role and modes of operation of *X. citri* 'Hrp pilus' in biofilm formation and motility.

Conclusions
===========

This work demonstrates that the presence of T3SS in *X. citri*, besides its participation in the secretion of effector proteins is also required for biofilm formation, motility and survival on leaf tissue revealing novel functions for this secretion system in *X. citri*. In biofilm formation, T3SS may have an important role in modulating adaptive changes that lead to this process. Some of these changes are revealed by variations in proteins involved in metabolic processes, energy generation, EPS production and bacterial motility as well as in outer membrane proteins between the wild type strain and the T3SS mutant. In summary, the present study reveals novel contributions of this protein secretion system to bacterial virulence.

Methods
=======

Bacterial strains, culture conditions and media
-----------------------------------------------

*X. citri* strain Xac99-1330 was isolated from *C. sinensis* and kindly provided by Blanca I. Canteros (INTA Bella Vista, Argentina). The *hrpB*^−^ mutant was constructed in previous work \[[@B19]\]. Here, *hrpB*^−^c complemented strain was constructed by cloning the region from *hrpB5* to *hrcT* in the replicative plasmid pBBR1MCS-5 \[[@B20]\] under the control of the *lacZ* promoter. This region was amplified from *X. citri* genomic DNA with the oligonucleotides: HrpB5F-Hind (5′ ATAGAAGCTTCATGCGTCTCTGGTTGAGGTC 3′) and HrcTR-Bam (5′ ATCAGGATCCTCAGTGCGACGCGGCTCTCT 3′) and cloned into pBBR1MCS-5 previously digested with the restriction enzymes *Hind*III and *Bam*HI. The resulting construction was electroporated into the *hrpB*^−^ strain and the complemented mutant strain was selected by for gentamicin antibiotic resistance. For confocal laser scanning microscopy analyses, a GFP-expressing *hrpB*^*−*^ strain was obtained. To this end, the coding sequence for EGFP from the broad-host-range vector pBBR1MCS-2EGFP \[[@B16]\] was digested with *BamH*I and *Xba*I and ligated in frame with the LacZ-α-peptide of the pBBR1MCS-5 vector \[[@B20]\] previously digested with the same enzymes, rendering the plasmid pBBR1MCS-5EGFP. *E. coli* S17-1 cells transformed with this plasmid were conjugated with the *hrpB*^−^ strain and the cells carrying the plasmid pBBR1MCS-5EGFP were selected for Gm resistance. All strains were grown at 28°C in Silva Buddenhagen (SB) medium \[[@B16]\] or in XVM2 medium \[[@B49]\]. Antibiotics were used at the following final concentrations: 25 μg/ml ampicillin (Amp), 5 μg/ml gentamicin (Gm) and 40 μg/ml kanamycin (Km).

Plant material
--------------

Orange (*Citrus sinensis* cv. Valencia) was used as the host plant for *X. citri*. All plants were grown in a growth chamber with incandescent light at 28°C with a photoperiod of 16 h.

Biofilm assays
--------------

For biofilms development, bacteria were grown in SB with shaking until exponential growth phase and then diluted 1:10 in fresh XVM2 medium containing appropriate antibiotics. A 2 ml aliquot of diluted bacterial suspension was placed in borosilicate glass tubes or in 24-well PVC plates and incubated statically for seven days at 28°C. The quantification of biofilm formation by CV staining was carried out as previously described \[[@B50]\]. Briefly, the culture medium was decanted and the absorbance of planktonic cells was measured at 600 nm using a UV-visible spectrophotometer (Synergy 2 Reader, BioTek). After washing the tubes three times with distilled water (dH~2~O) during 10 min with gentle agitation, the remaining attached cells were incubated for 10 min at 60°C and stained with 0.1% (w/v) CV for 30 min at room temperature. Excess CV stain was removed by washing under running tap water. The CV stain was solubilized by the addition of 1.5 ml ethanol:acetone (80:20, v/v) to each tube and quantified by measuring the absorbance at 600 nm. The relative absorbance (Relative abs.) was calculated as: CV Abs. 600 nm/Planktonic cells Abs. 600 nm. Values represent the mean from seven tubes for each strain, data were statistically analyzed using one-way analysis of variance (ANOVA) (p \< 0.05).

Confocal analysis of biofilm architecture
-----------------------------------------

*In vitro* biofilm of the GFP-expressing *hrpB*^−^ mutant and *X. citri* previously constructed \[[@B16]\] grown in 24-well PVC plates in XVM2 medium were analyzed after seven days by confocal laser scanning microscopy (Nikon Eclipse TE-2000-E2). For biofilms assays on leaf surfaces, overnight cultures of both GFP-expressing strains grown in XVM2 medium were centrifuged, washed and resuspended in phosphate buffer (pH 7.0) to the same OD~600~ and 20 μl of each bacterial suspension were applied on abaxial leaf surfaces. These biofilms were also analyzed after seven days by confocal laser scanning microscopy (Nikon Eclipse TE-2000-E2).

Adhesion assays
---------------

The adhesion capacity to leaf surfaces was measured as described previously \[[@B16]\]. Overnight cultures of the different strains in XVM2 medium were centrifuged to recover cell pellets, washed and resuspended in phosphate buffer (pH 7.0) to the same optic density measured at 600 nm (OD600). Then, 20 μl of each bacteria suspension were place on abaxial leaf surfaces and incubated for 6 h at 28°C in a humidified chamber. After washing the non-adhered cells, bacteria were stained with CV, the CV stain was extracted from the bacterial drops with 95% (v/v) ethanol by pipetting up and down with a 20 μl micropipette. Quantification of the extracted CV stain was carried out by measuring the absorbance at 590 nm as described above. For each strain 20 stained drops were quantified and data were statistically analyzed using one-way ANOVA (p \< 0.05).

Quantification of leaf-associated survival
------------------------------------------

Leaf-associated fitness was evaluated as previously described \[[@B51]\]. Briefly, overnight cultures in SB medium were centrifuged to recover bacteria cell pellets, washed and resuspended in 10 mM phosphate buffer (pH 7.0) at a concentration of 10^9^ CFU/ml. These bacterial suspensions were sprayed onto leaves until each leaf surfaces were uniformly covered. Old citrus leaves were used since the greater thickness of the cuticles of these leaves naturally render the leaves resistant to bacterial entry (unpublished results). Four different leaves were inoculated with each strain, leaves were photographed and the surfaces were quantified using the software Image-Pro (Media Cybernetics). Leaves were collected on different days post-inoculation and transferred to borosilicate glass flasks containing 10 mM potassium phosphate buffer (pH 7.0). Flasks were submerged in a sonicator (Branson model \#5510) for 10 min. Subsequently, each flask was vortexed for 5 sec, bacteria were recovered by centrifugation and serial dilutions were plated on SB plates containing Ap to count bacterial colonies. Results were expressed in CFU/cm^2^ of inoculated leaves. Values represent an average of four leaves assayed for each strain, the data were statistically analyzed using one-way ANOVA (p \< 0.05).

RNA preparation and RT-qPCR
---------------------------

Total RNA from bacterial cultures grown at the indicated conditions and from bacteria recovered from leaves at the indicated times were isolated using TRIzol® reagent (Invitrogen), according to the manufacturer's instructions. The RT-qPCRs were performed as previously described \[[@B52]\] with the specific oligonucleotides detailed in Additional file [3](#S3){ref-type="supplementary-material"}: Table S1. As a reference gene, a fragment of 16S rRNA (XAC3896) was amplified using the same RT-qPCR conditions. To control that no bacterial DNA contamination was present in the samples, the same PCR reactions were carried out without retrotranscription and non amplification was observed. To ascertain the absence of plant RNA in bacterial samples controls with plant actin primers were carried out (data not shown). Values were normalized by the internal reference (Ct~r~) according to the equation ΔCt = Ct -- Ct~r~, and quantified as 2^--ΔCt^. A second normalization using a control (time = 0 days) (Ct~c~), ΔΔCt = Ct -- Ct~c~, producing a relative quantification: 2^--ΔΔCt^\[[@B53]\]. Values are the means of four biological replicates with three technical replicates each. Results were analyzed by Student *t*-test (p \< 0.05) and one-way ANOVA (p \< 0.05).

Protein extraction and resolubilization for the proteomic analysis
------------------------------------------------------------------

Biofilms of statically grown bacterial cultures were obtained as previously described \[[@B42]\]. After seven days of static growth, the XVM2 medium was carefully removed and biofilms were collected by pipetting, transferred to a new tube and pelleted by centrifugation prior to protein extraction. Biofilm proteins were extracted and resuspended in urea buffer (9 M urea, 2 M thiourea and 4% (w/v) 3-\[(3-cholamidopropyl)dimethylammonio\]-1-propanesulfonate (CHAPS)) with vigorous vortexing at room temperature. Concentration of total protein extracts was estimated using a modified Bradford assay \[[@B54]\] and using bovine serum albumin as standard. Protein extracts were prepared from three biological replicates for each strain.

Proteomic analyses
------------------

Total proteins from biofilm cells were extracted and labeled using the fluorescent cyanine three-dye strategy (CyDyes; GE Healthcare), as described in \[[@B42]\]. *X. citri* and *hrpB*^−^ protein samples were labeled with Cy3 and Cy5, respectively, according to manufacturer's instructions. Protein extractions were performed from three independent biological samples, and two technical replicate gels for each experiment were run. Protein separation, quantification by two-dimensional-difference in-gel electrophoresis (2D-DIGE), comparative analysis and protein identification were also carried out as previously described \[[@B42]\]. Normalized expression profile data were used to statistically assess changes in protein spot expression. Differentially expressed protein spots between the two groups were calculated using the Student *t*-test with a critical p-value ≤ 0.05 and the permutation-based method to avoid biased results that may arise within replicate gels if spot quantities are not normally distributed. The adjusted Bonferroni correction was applied for false discovery rate (FDR) to control the proportion of false positives in the result set. Principal component analysis was performed to determine samples and spots that contributed most to the variance and their relatedness. Protein spots with a minimum of 1.5 fold change and p values \< 0.05 only were considered as significantly differentially expressed between the two strains.

Quantification of EPS production
--------------------------------

Quantification of EPS production was performed as previously described \[[@B55]\]. Briefly, bacterial strains were cultured to the stationary growth phase in 50 ml of SB liquid medium supplemented with 1% (w/v) glucose in 250 ml flasks, using an orbital rotating shaker at 200 rpm at 28°C. Cells were removed by centrifugation at 2,500 × g for 30 min at room temperature, and the supernatant fluids were separately supplemented with KCl at 1% (w/v) and 2 volumes of 96% (v/v) ethanol and then incubated for 30 min at -20°C to promote EPS precipitation. Precipitated crude EPS were collected, dried and weighed. Results were expressed in grams per culture liter. Quadruplicate measurements were made for each strain and an average of all measurements was obtained, data were statistically analyzed using one-way ANOVA (p \< 0.05).

Swimming and swarming assays
----------------------------

Swimming and swarming motility were measured as previously described \[[@B16]\]. The SB plates fortified with 0.3% (w/v) or 0.7% (w/v) agar respectively were centrally inoculated with 5 μl of 1 × 10^7^ CFU/ml cultures in exponential growth phase. Inoculated Petri dishes were then incubated in a humidity chamber for two days at 28°C and the motility zones were measured. Results are the average of the motility zones of sixteen Petri dishes per strain. Data was statistically analyzed using one-way ANOVA (p \< 0.05).

Competing interests
===================

The authors declare that they have no competing interests.

Authors' contributions
======================

JO and NG conceived the project and designed the experiments. TZ, LT, CM, GGS, CGG, FAF and NG designed and performed the experiments. All authors contributed to the analysis and interpretation of the data and LT, CM, CG, JO and NG wrote the manuscript. All authors read and approved the manuscript.

Supplementary Material
======================

###### Additional file 1: Figure S1

Characterization of the *hrpB*^*−*^ complemented strain on HR and pathogenicity. (A) Schematic organization of the *hrp* cluster of *X. citri* that was constructed based on the *X. citri subsp. citri* strain 306 genome sequence \[[@B1]\]. Boxes correspond to ORFs, arrows indicate orientation of the *hrp* operons. The *hrp*, *hpa* and *hrc* genes are indicated. Dotted boxes indicated the genomic regions replaced by mutagenesis. Bellow of the scheme, the black box represents the genomic fragment cloned in pBBR1MCS-5 to complement the *hrpB*^*−*^ mutant strain. (B) Bacterial suspensions of *X. citri*, the *hrpB*^*−*^ mutant and the *hrpB*^*−*^c strains were inoculated at 10^8^ CFU/ml into the intercellular spaces of fully expanded tomato, cotton and pepper leaves. A representative photograph of a leaf is shown after 1 day of inoculation. (C) As in B, bacterial suspensions at 10^7^ CFU/ml were inoculated into the intercellular spaces of fully expanded citrus leaves. A representative photograph of a leaf is shown after 8 days of inoculation. (D) RT-qPCR to determine *CsLOB1* expression levels in leaves after 48 hours of infection with *X. citri*, the *hrpB*^*−*^ mutant and *hrpB*^*−*^c strain. Bars indicate the expression levels relative to buffer infiltrations. Values are the means of four biological replicates with three technical replicates each.
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###### Additional file 2: Figure S2

Swimming and swarming assays. Representative photographs of Petri dishes with *X. citri*, the *hrp* mutants and the *hrpB*^*−*^c strain after 2 days of inoculation. Scale bars: 10 mm.
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###### Additional file 3: Table S1

Oligonucleotides used in RT-qPCR assays.
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